Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2005

01-02-2004 | Commentary

Ethics roundtable debate: A patient dies from an ICU-acquired infection related to methicillin-resistant Staphylococcus aureus – how do you defend your case and your team?

Authors: Jean-Louis Vincent, Christian Brun-Buisson, Michael Niederman, Christian Haenni, Stephan Harbarth, Dominique Sprumont, Mauricio Valencia, Antoni Torres

Published in: Critical Care | Issue 1/2005

Login to get access

Abstract

An elderly patient dies from septic shock in the intensive care unit. This is perhaps not an unusual scenario, but in this case the sepsis happens to have been due to methicillin-resistant Staphylococcus aureus, possibly related to a catheter, and possibly transmitted from a patient in a neighbouring room by less than adequate compliance with infection control procedures. The family decides to sue. We present how experts from four different countries assess the medicolegal issues involved in this case.
Literature
1.
Vincent JL: Nosocomial infections in adult intensive-care units. Lancet 2003, 361: 2068-2077. 10.1016/S0140-6736(03)13644-6CrossRefPubMed
2.
Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth G, Lai R, Ebrahim S: Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ 2004, 329: 533. 10.1136/bmj.329.7465.533PubMedCentralCrossRefPubMed
3.
4.
Boyce JM, Havill NL, Kohan C, Dunnigan DG, Ligi CE: Do Infection control measures work for methicillin-resistant Staphylococcus aureus ? Infect Control Hosp Epidemiol 2004, 25: 395-401.CrossRefPubMed
5.
Gnass SA, Barboza L, Bilicich D, Angeloro P, Treiyer W, Grenovero S, Basualdo J: Prevention of central venous catheter-related bloodstream infections using non-technologic strategies. J Infect Control Hosp Epidemiol 2004, 25: 675-677.CrossRef
6.
Harbarth S, Martin Y, Rohner P, Henry N, Auckenthaler R, Pittet D: Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus . J Hosp Infect 2000, 46: 43-49. 10.1053/jhin.2000.0798CrossRefPubMed
7.
Lee SC, Chen KS, Tsai CJ, Lee CC, Chang HY, See LC, Kao YC, Chen SC, Wang CH: An outbreak of methicillin-resistant Staphylococcus aureus infections related to central venous catheters for hemodialysis. Infect Control Hosp Epidemiol 2004, 25: 678-684.CrossRefPubMed
8.
Hospital Infection Society and British Society for Antimicrobial Chemotherapy: Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. J Hosp Infect 1998, 39: 253-290. 10.1016/S0195-6701(98)90293-6CrossRef
9.
Pittet D, Mourouga P, Perneger TV: Compliance with hand washing in a teaching hospital. Ann Intern Med 1999, 130: 126-130.CrossRefPubMed
10.
Studdert DM, Mello MM, Burns JP, Puopolo AL, Galper BZ, Truog RD, Brennan TA: Conflict in the care of patients with prolonged stay in the ICU: types, sources, and predictors. Intensive Care Med 2003, 29: 1489-1497. 10.1007/s00134-003-1853-5CrossRefPubMed
11.
Fellmann W, Poledna T: Liability and malpractice in healthcare. Current issues and controversies [in German]. Edited by: Fellmann W, Poledna T. Schulthess: Forum Gesundheitsrecht 7; 2003.
12.
Guillod O, Rapin C: Medical litigation in Switzerland [in French]. In In La Responsabilité: Aspects Nouveaux. Paris, France: Travaux de l'association Henri Capitant; 2000:375-412.
13.
Bobinski MA: Legal issues in hospital epidemiology and infection control. In In Hospital Epidemiology and Infection Control. 3rd edition. Edited by: Mayhall CG. Philadelphia: Lippincott Williams & Wilkins; 2004:1835-1845.
14.
Runciman WB, Merry AF, Tito F: Error, blame, and the law in health care: an antipodean perspective. Ann Intern Med 2003, 138: 974-979.CrossRefPubMed
15.
Pakarinen S: Incidence, etiology and prognosis of primary subarachnoid haemorrhage: a study based on 589 cases diagnosed in a defined urban population during a defined period. Acta Neurol Scand (Suppl) 1967, 29: 1-28.
16.
Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Boone SC, Chou SN, Kelly DL, Weir BK, Crabbe RA, et al.: Cerebral arterial spasm: a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 1983, 308: 619-624.CrossRefPubMed
17.
Sen J, Belli A, Albon H, Morgan L, Petzold A, Kitchen N: Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol 2003, 2: 614-621. 10.1016/S1474-4422(03)00531-3CrossRefPubMed
18.
Marshall C, Harrington G, Wolfe R, Fairley CK, Wesselingh S, Spelman D: Acquisition of methicillin-resistant Staphylococcus aureus in intensive care unit. Infect Control Hosp Epidemiol 2003, 24: 322-326.CrossRefPubMed
19.
Moreno F, Crisp C, Jorgensen JH, Patterson JE: Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis 1996, 21: 1308-1312.CrossRef
20.
Garrouste-Orgeas M, Timsit JF, Kallel H, Ben Ali A, Dumay MF, Paoli B, Misset B, Carlet J: Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality and glycopeptide use. Infect Control Hosp Epidemiol 2001, 22: 687-692.CrossRefPubMed
21.
Boyce JM: Methicillin-resistant Staphylococcus aureus : detection, epidemiology, and control measures. Infect Dis Clin North Am 1989, 3: 901-913.PubMed
22.
Garner JS: Hospital infection control practices advisory committee. Guidelines for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996, 17: 53-80.CrossRefPubMed
23.
Zafar AB, Butler RC, Reese DJ, Gaydos LA, Mennonna PA: Use of 0.3% triclosan to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 1989, 143: 34-39.
24.
Hartstein AL, LeMonte AM, Iwamoto PK: DNA typing and control of methicillin-resistant Staphylococcus aureus in a hospital and an intensive care unit. Infect Control Hosp Epidemiol 1995, 16: 405-411.CrossRefPubMed
25.
Jernigan JA, Titus MG, Groschel DH, Getchell-White S, Farr BM: Effectiveness of contact isolation during an outbreak of methicillin-resistant Staphylococcus aureus . Am J Epidemiol 1996, 143: 496-504.CrossRefPubMed
Metadata
Title
Ethics roundtable debate: A patient dies from an ICU-acquired infection related to methicillin-resistant Staphylococcus aureus – how do you defend your case and your team?
Authors
Jean-Louis Vincent
Christian Brun-Buisson
Michael Niederman
Christian Haenni
Stephan Harbarth
Dominique Sprumont
Mauricio Valencia
Antoni Torres
Publication date
01-02-2004
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2005
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc3016

Other articles of this Issue 1/2005

Critical Care 1/2005 Go to the issue

Review

Statistics review 14: Logistic regression

Review

Pro/con clinical debate: It is acceptable to stop large multicentre randomized controlled trials at interim analysis for futility

Review

Science review: The brain in sepsis – culprit and victim

Research

Effect of magnesium sulfate administration on blood–brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study

Research

Timing of tracheostomy as a determinant of weaning success in critically ill patients: a retrospective study

Commentary

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis